CLINICOACH Canadian Trademark Information

On Thursday, July 11, 2019, a canadian trademark registration was filed for CLINICOACH by H. Lundbeck A/S *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 2006332. The current status of this trademark filing is Registration published. The CLINICOACH trademark is filed in the description of Pharmaceuticals and medical preparations and substances; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants. , Pharmaceutical preparations and medical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations, medical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; vaccines for human use; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; pharmaceutical preparations and substances acting on the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases; central nervous system stimulants. , Pharmaceutical research and development; scientific and technological services, namely research in the field of the central nervous system and central nervous system related disorders, diseases and pharmaceuticals, and design of pharmaceuticals for the central nervous system and central nervous system related disorders and diseases; medical research and tests; clinical research and tests in the field of neurology; diagnostic research and tests in the field of neurology; providing on-line non-downloadable tools, namely software for the assessment of cognitive functions; providing online non-downloadable tools, namely software for diagnosing, managing, monitoring, assessing, measuring, controlling and examining psychiatric and neurological disorders and diseases. , Pharmaceutical research and development; scientific and technological services and research and design relating thereto related to the central nervous system and central nervous system related disorders, diseases and pharmaceuticals; medical research and tests; clinical research and tests; diagnostic research and tests; providing on-line non-downloadable tools (software) for assessment of cognitive functions; providing online non-downloadable tools (software) for diagnosing, managing, monitoring, assessing, measuring, controlling and examining psychiatric and neurological disorders and diseases. .